BMO Capital analyst Michael Zaremski initiates coverage on RenaissanceRe Holdings (NYSE:RNR) with a Market Perform rating and announces Price Target of $187.
Where Immunocore Hldgs Stands With Analysts
10 analysts have shared their evaluations of Immunocore Hldgs (NASDAQ:IMCR) during the recent three months, expressing a mix…